We are incredibly excited to announce the launch of Ring of Support in collaboration with our clinical partner, SE Health. Ring of Support is an intelligent personalized and multi-modal engagement platform using the Amazon Alexa Voice Assistant, home telephones and mobile messaging. Ring Of Support was created to support individuals […]
Introducing Dot the Diabetes Carebot… Advanced analytics and machine learning have the potential to be game changers in the detection and management of diabetes. In the new year, in partnership with the health analytics company, MEMOTEXT and Green Shield Canada (GSC) GSC launch Dot the Diabetes Carebot. Dot is a chatbot […]
Members of SOFIA from our collaborative venture with Massachusetts General Hospital (MGH) presented on our joint ADHD adherence initiative at APSARD 2019. The SOFIA (Simple Online Family Intervention for ADHD) system is a co-commercialized initiative between MEMOTEXT and Massachusetts General Hospital (MGH), Partners Healthcare led by Dr. Joseph Biederman Chief, Clinical […]
Co-written by Amos Adler (MEMOTEXT) and Donna Hui (ARIAD HEALTH/BLUESPIRE), February 6, 2017 First there was Eliza. Developed in the 60s, Eliza was a psychotherapist bot that would recognize keywords as they were typed, mirror them back to the user – and then ask how he or she felt about […]
The HIV Prevention Trials Network (HPTN) has launched a research study examining the feasibility and scalability of an integrated, enhanced, case manager care strategy to attain and maintain viral suppression among HIV-infected men who have sex with men (MSM) in the United States. The study is being conducted in four […]
MEMOTEXT is returning to Stanford MedX! On Sunday September 18 @ 11:00AM come and visit us in the lower lobby. We will be presenting our poster entitled: Using personalized digital health behavior change to manage asthma.Check out our abstract below and hopefully we’ll see you there! If you can’t make […]
The Balanced Adherence Metric (BAM): a new spin on current methods for calculating adherence with pharmacy claims data. Bill Simpson, B.Sc, Ph.D (1,2) and Amos Adler, M.Sc. (2) McMaster University, Hamilton, Ontario, Canada MEMOTEXT Corporation, Toronto, Ontario, Canada Purpose/Objective: While Proportion of Days Covered (PDC) quantifies adherence […]
Posted on February 12, 2015
On February 11, 2014, MEMOTEXT was one of the 5 MaRS based mHealth/digital health start-ups, invited to speak at the University of Toronto’s Rotman School of Management’s IT in Healthcare Speaker Series: Start-Ups. MEMOTEXT Founder and President Amos Adler spoke about how MEMOTEXT’s mhealth/digital health communication platform cuts costs for all stakeholders in the healthcare system and delivers clinically proven increases to adherence.
TORONTO, Feb. 4, 2016 /CNW/ – A 2014 pilot program for patients with chronic diseases by Green Shield Canada (GSC) and MEMOTEXT Corp. has revealed some new facts about non-adherence to medication. Compiled into “The Importance of Sticking to it” whitepaper, data from the Stick2It program shows that a […]
Looking back on MEMOTEXT’s accomplishments this fall
Posted on December 2, 2015 by Noah Nemoy
This autumn has been an exciting time for MEMOTEXT. In September our Founder and President Amos Adler had the opportunity to be a main stage speaker at Stanford Medicine X 2015. Presenting the abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” Amos rocked the crowd explaining the MEMOTEXT methodology. He had a fantastic time at the event and the “Cat pics + health data = behavior change” line got a substantial amount of press coverage.